Cholera vaccine inactivated oral - International Vaccine Institute

Drug Profile

Cholera vaccine inactivated oral - International Vaccine Institute

Alternative Names: Euvichol; ShanChol

Latest Information Update: 01 Jul 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator International Vaccine Institute
  • Developer EuBiologics; Incepta Vaccine; International Centre for Diarrhoeal Disease Research; International Vaccine Institute; Shantha Biotechnics
  • Class Cholera vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Cholera

Most Recent Events

  • 15 Jun 2017 International Vaccine Institute completes a phase II trial in Cholera (In adolescents, In children, In infants, Prevention, In adults) in Bangladesh (PO) (NCT02742558)
  • 28 Oct 2016 Cholvax® is still in clinical trials for Cholera in South Korea (International Vaccine Institute website, October 2016)
  • 16 Jul 2016 No recent reports of development identified for phase-I development in Cholera(Prevention) in South Korea (PO, Suspension)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top